Reframing the Approach to Patients With Hepatocellular Carcinoma: Longitudinal Assessment With HALTHCC Improves Ablate and Wait Strategy

Hepatology - United States
doi 10.1002/hep.29907
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance

JAMA network open
Medicine
2019English

The Critical Issue of Restaging Patients With Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Liver Stiffness Measurement in the Risk Assessment of Hepatocellular Carcinoma for Patients With Chronic Hepatitis

Hepatology International
Hepatology
2010English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

The Impact of Thyroid Hormones on Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

A New Approach to the Use of Α-Fetoprotein as Surveillance Test for Hepatocellular Carcinoma in Patients With Cirrhosis

British Journal of Cancer
Cancer ResearchOncology
2014English

Clinical Manifestations and Outcomes of Patients With Sarcomatoid Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Optimal Follow-Up of Patients With Viral Hepatitis Improves the Detection of Early-Stage Hepatocellular Carcinoma and the Prognosis of Survival

Internal Medicine
Internal MedicineMedicine
2016English

Models of Hepatocellular Carcinoma and Biomarker Strategy

Cancers
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy